Clinical Trial 22712

A Phase 1B/2 Dose-finding and Expansion Study Evaluating the Safety and Efficacy of Zanzalintinib (XL092) Combined with either AB521 or AB521 plus Nivolumab in Subjects with Advanced Clear Cell Renal Cell Carcinoma or other Advanced Solid Tumors

Disease Site: Colon, Prostate, Rectum

PI: Chahoud, Jad

Clinical Trial 22713

Disease Site: Any Site

PI: Soliman, Hatem

Clinical Trial 23098

A Phase IB Clinical Study of TBio-4101 (Autologous Selected and Expanded Tumor-Infiltrating Lymphocytes [TIL]) and Pembrolizumab with or without chemotherapy in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Cancer (HNSCC)

Disease Site: Eye and Orbit, Lip, Oral Cavity and Pharynx

PI: Kirtane, Kedar

Clinical Trial 23200

Phase III Trial of Stereotactic Radiosurgery (SRS) versus Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for 10 or fewer Brain Metastases from Small Cell Lung Cancer

Disease Site: Lung

PI: Yu, Hsiang-Hsuan (Michael)

Clinical Trial 20030

TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive and T3N0 Positive Breast Cancer

Disease Site: Breast

PI: Washington, Iman

Clinical Trial 19836

REPLATINUM: A Phase 3, Controlled, Open-label,Randomized Study of RRx-001 Administered Sequentially with a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond Small Cell Lung Cancer

Disease Site: Lung

PI: Chiappori, Alberto

Clinical Trial 19662

Phase II study of stereotactic body radiation therapy and atezolizumab in the management of recurrent, persistent, or metastatic cervical cancer

Disease Site: Cervix

PI: Ahmed, Kamran

Clinical Trial 20832

A Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization in Patients with Localized Prostate Carcinoma and Obstructive Lower Urinary Tract Symptoms

Disease Site: Prostate

PI: Parikh, Nainesh

Clinical Trial 20373

TH-138: Phase II Randomized Trial of Carboplatin + Pemetrexed + Bevacizumab, With or Without Atezolizumab in Stage IV Non-Squamous NSCLC Patients who Harbor a Sensitizing EGFR Mutation or Have Never Smoked

Disease Site: Non small cell lung cancer, Lung

PI: Pellini, Bruna

Clinical Trial 21460

Phase Ib Trial of Erdafitinib Combined with Enfortumab Vedotin Following Platinum and PD1/L1 Inhibitors for Metastatic Urothelial Carcinoma with FGFR2/3 Genetic Alterations

Disease Site: Other Urinary

PI: Jain, Rohit

Clinical Trial 21551

A Phase 2, Open-Label Randomized Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone vs Carfilzomib, Lenalidomide, and Dexamethasone in Patients with Newly-Diagnosed Multiple Myeloma (ADVANCE)

Disease Site: Multiple Myeloma

PI: Shain, Kenneth

Clinical Trial 17425

Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck

Disease Site: Larynx, Lip, Oral Cavity and Pharynx

PI: Caudell, Jimmy